We are live on ! Find out more
SCM

Sio Capital Management Portfolio holdings

AUM $697M
1-Year Est. Return 79.73%
This Fund
S&P 500
This Quarter Est. Return
-13.49%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$298M
AUM Growth
-$121M
Cap. Flow
-$79.8M
Cap. Flow %
-26.73%
Top 10 Hldgs %
49.77%
Holding
104
New
36
Increased
13
Reduced
16
Closed
35

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$23.2M
2
NVST icon
Envista
NVST
+$21.9M
3
BSX icon
Boston Scientific
BSX
+$15.5M
4
BIIB icon
Biogen
BIIB
+$12.7M
5
GLD icon
SPDR Gold Trust
GLD
+$9.63M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$16.7M
2
PFE icon
Pfizer
PFE
+$14.9M
3
WCG
Wellcare Health Plans, Inc.
WCG
+$14.8M
4
GILD icon
Gilead Sciences
GILD
+$12.1M
5
GSK icon
GSK
GSK
+$9.62M

Sector Composition

Rank Sector Weight
1 Healthcare 83.72%
2 Financials 0.58%
3 Technology 0.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GSK icon
76
GSK
GSK
$106B
– –
-163,764
Closed -$9.62M
HALO icon
77
Halozyme
HALO
$12.2B
– –
-79,067
Closed -$1.4M
ITGR icon
78
Integer Holdings
ITGR
$4.26B
– –
-44,679
Closed -$3.59M
MDT icon
79
Medtronic
MDT
$112B
– –
-147,022
Closed -$16.7M
MMSI icon
80
Merit Medical Systems
MMSI
$5.32B
– –
-150,000
Closed -$4.68M
MTD icon
81
PUT
Mettler-Toledo International
MTD
$28.6B
– –
-400
Closed -$317K
OPK icon
82
Opko Health
OPK
$1.02B
– –
-805,311
Closed -$1.18M
OVID icon
83
Ovid Therapeutics
OVID
$491M
– –
-264,581
Closed -$1.1M
PFE icon
84
Pfizer
PFE
$153B
– –
-401,441
Closed -$14.9M
PHG icon
85
PUT
Philips
PHG
$26.1B
– –
-42,523
Closed -$1.65M
REGN icon
86
Regeneron Pharmaceuticals
REGN
$80.8B
– –
-24,776
Closed -$9.3M
SAGE
87
PUT
DELISTED
Sage Therapeutics
SAGE
– –
-41,900
Closed -$3.02M
SNY icon
88
Sanofi
SNY
$104B
– –
-170,977
Closed -$8.58M
WVE icon
89
CALL
Wave Life Sciences
WVE
$1.2B
– –
-219,100
Closed -$1.76M
XCUR icon
90
Exicure
XCUR
$8.54M
– –
-3,019
Closed -$1.29M
ITCI
91
PUT
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-1,946,800
Closed -$66.8M
RVNC
92
DELISTED
Revance Therapeutics, Inc.
RVNC
– –
-87,700
Closed -$1.42M
KRTX
93
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
– –
-9,588
Closed -$722K
SPPI
94
CALL
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
– –
-311,400
Closed -$1.13M
APTO
95
DELISTED
Aptose Biosciences, Inc.
APTO
– –
-111
Closed -$284K
LOGC
96
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
– –
-125,836
Closed -$906K
HRC
97
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
– –
-40,182
Closed -$4.56M
ALXN
98
DELISTED
Alexion Pharmaceuticals
ALXN
– –
-37,781
Closed -$4.09M
CMD
99
PUT
DELISTED
Cantel Medical Corporation
CMD
– –
-7,300
Closed -$518K
UROV
100
DELISTED
Urovant Sciences Ltd.
UROV
– –
-160,442
Closed -$2.49M
1 2 3
4
5

Similar funds

GUB
Golden Unicorn BVI Road Town $697M AUM 55.92% 1-Year Est. Return
KLI
Kelman-Lazarov Inc Memphis, Tennessee $698M AUM 14.07% 1-Year Est. Return
AAM
Auxier Asset Management Aurora, Oregon $696M AUM 18.07% 1-Year Est. Return
TCM
Tensile Capital Management Larkspur, California $698M AUM 2.4% 1-Year Est. Return
CA
Calton & Associates Tampa, Florida $696M AUM 18.3% 1-Year Est. Return
SAM
Silverback Asset Management Chapel Hill, North Carolina $699M AUM 72.42% 1-Year Est. Return
ACM
Academy Capital Management Waco, Texas $699M AUM 12.08% 1-Year Est. Return
MCM
Manchester Capital Management Manchester, Vermont $694M AUM 22.34% 1-Year Est. Return

Sio Capital Management's Q1 2020 Portfolio in Review

As of Q1 2020, Sio Capital Management held 104 positions worth $298M, down 29% from $420M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Sio Capital Management withdrew a net $79.8M in Q1 2020, closing 35 positions and reducing 16 holdings. Its most notable exit was Medtronic, an estimated $16.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, up from 72% a quarter earlier, followed by Financials and Technology.

Against the trend, Sio Capital Management opened a new position in Amgen worth $21.5M.

  • Sio Capital Management's largest Q1 2020 buy was Amgen: 106,069 shares worth $21.5M.
  • Sio Capital Management added most to McKesson in Q1 2020, an estimated $9.36M increase.
  • Sio Capital Management's biggest Q1 2020 reduction was Trillium Therapeutics Inc., cutting an estimated $8.82M.
  • Sio Capital Management fully exited Medtronic in Q1 2020, selling an estimated $16.7M.
  • Sio Capital Management's ten largest holdings make up 50% of its $298M portfolio in Q1 2020.
  • Sio Capital Management opened 36 new positions and closed 35 in Q1 2020.
  • Sio Capital Management's portfolio value fell 29% quarter-over-quarter to $298M.

Based on Sio Capital Management's 13F filing for Q1 2020, filed 15 May 2020.